Summary
Overview
Work History
Education
Volunteer Experience
Timeline
Generic

Paul L. Briuglio

New Orleans

Summary

Award winning Rare Disease sales performer with demonstrated patient identification skills. Extensive experience removing barriers to treatment working in a collaborative environment to exceed objectives.

Overview

21
21
years of professional experience

Work History

Rare Disease Specialist

Amicus Therapeutics
01.2023 - Current
  • TOP of the FOLD 2024
  • TOP of the FOLD 2023 (Circle of Excellence for new patient referrals and revenue growth)
  • 30% growth YoY in 2024 with 2.6 million dollar growth (2 out of 14)
  • 66% growth YoY in 2023 with 3.4 million dollar growth (1 out of 14)
  • 6 new pompe patients 2024 (2 out of 14)
  • Cross-functional team engagement with case manager, patient education liaison and MSL
  • Launch a new enzyme replacement therapy for LOPD (Pombiliti/Opfolda) in October 2024
  • Remove barriers to treatment for patients including formulary, prior auth and specialty pharmacy
  • Set up and in-service new infusion centers for new pompe patients

Clinical Oncology Specialist – Rare Disease Women’s Oncology

AstraZeneca Oncology
08.2020 - 12.2022
  • 2021 Circle of Excellence rank - 5/77
  • 53% growth with new patient identification and revenue goals
  • Virtual launch of new indication first line treatment for BRCA+ and HRD mutated ovarian cancer
  • Targets- Gynecology Oncology, Oncology, Genetic Counselors (Mississippi/Louisiana)
  • Genetic Testing companion diagnostic for BRCA and HRD patient identification (Blood and Tumor)
  • Tumor types include advanced genetically mutated ovarian, breast and pancreatic cancer

Senior Area Business Manager III – US Genetics/Rare Disease

Sanofi/Genzyme
09.2013 - 08.2020
  • 2016 – Circle of Excellence Award Winner
  • 2015 – Promoted to Level 3
  • 2014 – Gulf Coast Regional CSA of the year award
  • Enzyme Replacement Therapies for Lysosomal Storage Disorders: Gaucher, Fabry, Pompe, MPS 1
  • Launched first Oral Substrate reduction therapy for Gaucher disease in Genetics and Hematology
  • Coordinated testing, reimbursement, and infusion site recognition
  • Targeted Genetics, Endocrinology, Hematology/Oncology, Nephrology, Neurology, MDA Clinics, NKF
  • Remove barriers to treatment for patients including formulary, prior auth and specialty pharmacy
  • Cross-functional team engagement with case manager, patient education liaison and MSL
  • Partnered with MDA clinic coordinator and National Kidney Foundation director for disease outreach

Clinical Science Associate – Rare Disease Endocrine/Cardiovascular

Sanofi/Genzyme Rare
11.2003 - 09.2013
  • 2012 - Circle of Excellence Award Winner Afirma Launch
  • 2011 - Vice President’s MVP Award Winner West
  • Launched Thyrogen (Thyroid Cancer) in Oncology, Endocrinology, Nuclear Medicine, Radiation Onc
  • Launched Diagnostic Liquid Biopsy (Afirma) to uncover indeterminate Thyroid Nodules
  • Launched Kynamro for Familial Hypercholesterolemia to Cardiologist and Lipid Centers
  • Extensive Buy and Bill experience in office and hospital
  • Cross Collaboration with Case Manager to expedite Thyrogen orders through HUB
  • Served as Field marketing Liaison – 2005, 2007 Thyrogen

Education

Bachelor of Science - Marketing

University of New Orleans
New Orleans, LA

Volunteer Experience

  • Take Paws Rescue, Train and domesticate dogs for adoption to their forever homes and fund raising
  • Miracle League, Basketball Coach and Official
  • Certified Basketball Official

Timeline

Rare Disease Specialist

Amicus Therapeutics
01.2023 - Current

Clinical Oncology Specialist – Rare Disease Women’s Oncology

AstraZeneca Oncology
08.2020 - 12.2022

Senior Area Business Manager III – US Genetics/Rare Disease

Sanofi/Genzyme
09.2013 - 08.2020

Clinical Science Associate – Rare Disease Endocrine/Cardiovascular

Sanofi/Genzyme Rare
11.2003 - 09.2013

Bachelor of Science - Marketing

University of New Orleans

Similar Profiles

CREATE PROFILE
Paul L. Briuglio